A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ChromaDex increases capsule serving to 150mg TRU NIAGEN® (nicotinamide riboside), following successful New Dietary Ingredient (NDI) notification from FDA LOS ANGELES, Oct. 24, 2018 -- ChromaDex Corp. (NASDAQ:CDXC) announced today it has strengthened its flagship...
Frank Jaksch to speak on healthy aging and the research supporting TRU NIAGEN® in Berlin LOS ANGELES, Oct. 22, 2018 -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will present the science behind TRU NIAGEN® (nicotinamide riboside) at the 9th World...
Women's health practitioners now have access to TRU NIAGEN® PRO for aging patients LOS ANGELES, Oct. 03, 2018 -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it will highlight its new TRU NIAGEN® PRO product at the NAMS Annual Meeting 2018 in San...
LOS ANGELES, Oct. 02, 2018 -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has appointed Yan Chu as Managing Director, Asia Pacific, effective today. Based in Singapore, Chu will lead the TRU NIAGEN® business for the region. Chu is joining ChromaDex from...
Addressing professional athletes, trainers and active consumers, TRU NIAGEN product rigorously tested and does not contain over 272 athletic banned substances IRVINE, Calif., Sept. 24, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical...
Healthcare practitioners will have first look at new high-dose TRU NIAGEN PRO product IRVINE, Calif., Sept. 21, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship...
Addressing aging population, TRU NIAGEN PRO now available for distribution by healthcare practitioners for patient health and wellness IRVINE, Calif., Sept. 20, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to...
IRVINE, Calif., Sept. 18, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its flagship ingredient NIAGEN® and consumer product TRU NIAGEN®, announced today that...
New partnership between ChromaDex and First Affiliated Hospital of Nanchang University addresses China's rapidly aging population IRVINE, Calif., Sept. 17, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving...
Frank Jaksch, ChromaDex Co-Founder & Executive Chairman, to discuss nutraceuticals, aging, and NAD IRVINE, Calif., Sept. 11, 2018 -- ChromaDex Corp. (NASDAQ:CDXC), an integrated, science-based, nutraceutical company devoted to improving the way people age with its...